Illinois Municipal Retirement Fund’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Sell
45,965
-86,925
-65% -$4.76M 0.03% 543
2026
Q1
$7.51M Sell
132,890
-38,821
-23% -$2.26M 0.1% 249
2025
Q4
$10.2M Buy
171,711
+35,986
+27% +$1.96M 0.13% 190
2025
Q3
$7.35M Buy
135,725
+364
+0.3% +$20.8K 0.09% 263
2025
Q2
$7.44M Buy
+135,361
New +$7.97M 0.1% 249
2024
Q1
– Sell
-6,405
Closed -$618K – 1359
2023
Q4
$618K Hold
6,405
– – 0.01% 1142
2023
Q3
$567K Hold
6,405
– – 0.01% 1138
2023
Q2
$555K Hold
6,405
– – 0.01% 787
2023
Q1
$623K Hold
6,405
– – 0.01% 747
2022
Q4
$663K Hold
6,405
– – 0.01% 708
2022
Q3
$543K Buy
+6,405
New +$570K 0.01% 749
2021
Q2
– Sell
-5,979
Closed -$451K – 851
2021
Q1
$451K Hold
5,979
– – 0.02% 682
2020
Q4
$524K Buy
5,979
+2,667
+81% +$211K 0.02% 597
2020
Q3
$252K Buy
+3,312
New +$335K 0.03% 574

Other funds holding BMRN

Illinois Municipal Retirement Fund's BMRN Position: Q2 2026 in Review

Illinois Municipal Retirement Fund reduced its BioMarin Pharmaceuticals (BMRN) stake by 65% in Q2 2026, selling an estimated $4.76M and leaving 45,965 shares worth $2.63M. The position accounts for 0.03% of the portfolio, ranked #543.

Illinois Municipal Retirement Fund first reported a position in BMRN in Q3 2020 and has held it in 14 quarters since. The position peaked at $10.2M in Q4 2025. 566 funds tracked by Wall St. Rank hold BMRN as of Q2 2026.

  • Illinois Municipal Retirement Fund held 45,965 shares of BioMarin Pharmaceuticals worth $2.63M as of Q2 2026.
  • Illinois Municipal Retirement Fund sold 86,925 BioMarin Pharmaceuticals shares in Q2 2026, an estimated $4.76M.
  • BioMarin Pharmaceuticals made up 0.03% of Illinois Municipal Retirement Fund's portfolio in Q2 2026, its #543 holding.
  • Illinois Municipal Retirement Fund first reported a position in BioMarin Pharmaceuticals in Q3 2020 and has held it in 14 quarters since.
  • Illinois Municipal Retirement Fund's BioMarin Pharmaceuticals position peaked at $10.2M in Q4 2025.
  • 566 funds tracked by Wall St. Rank held BioMarin Pharmaceuticals as of Q2 2026.

Based on Illinois Municipal Retirement Fund's 13F filing for Q2 2026, filed 12 Aug 2026.